[3 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [August 2019]

skin cancer update

In this month’s skin cancer update video, Professor Giuseppe Argenziano discusses how a new therapeutic agent, cemiplimab, might be used in combination with radiotherapy to treat advanced squamous cell carcinoma. Continue reading “[3 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [August 2019]”

[4 min read] Breast cancer drug may treat mucosal melanoma

mucosal melanoma

A drug typically used to treat breast cancer may also be effective in treating mucosal melanoma.

Mucosal melanoma is not linked to UV exposure and is extremely difficult to treat. It occurs on moist tissues inside the body, including the eyes, inside the mouth and nose, gastrointestinal areas and the genital tract.

Continue reading “[4 min read] Breast cancer drug may treat mucosal melanoma”

[2 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [July 2019]

skin cancer update

In this month’s skin cancer update video, Professor Giuseppe Argenziano talks about an interesting patient case that demonstrates the importance of performing an examination of the entire skin surface – even if the patient is only concerned about one particular lesion – and highlights how dermoscopy can both enhance and change our understandings of lesions in the clinical setting. Continue reading “[2 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [July 2019]”

[4 min read] Compounds found that starve melanoma cells of energy

melanoma

Researchers have identified compounds that starve melanoma cells of energy. Scientists at Oregon State University and Oregon Health & Science University have found a possible way of beating the drug resistance of melanoma, one of the deadliest forms of skin cancer. Continue reading “[4 min read] Compounds found that starve melanoma cells of energy”

[5 min read] First-line treatment decisions for BRAF-mutated melanoma

melanoma treatment
How do you determine first-line treatment for your patients with melanoma? Treatment decisions for advanced melanoma are increasingly complex and guidelines provide limited advice on how to choose between immunotherapy and targeted therapy for first-line treatment. A Delphi study was carried out to understand which patient characteristics and disease-related factors inform clinicians’ choices of first-line treatment for BRAF-mutated melanoma.

Continue reading “[5 min read] First-line treatment decisions for BRAF-mutated melanoma”

[4 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [June 2019]

skin cancer update

In this month’s skin cancer update video, Professor Giuseppe Argenziano continues his two-part discussion from last month about the role of Imiquimod in the treatment of lentigo maligna. Using real patient case examples, Giuseppe discusses Imiquimod in an adjuvant setting, including how it can be applied in a clinical setting after surgery has been performed. Continue reading “[4 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [June 2019]”

[3 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [May 2019]

skin cancer update

In this month’s skin cancer update video, Professor Giuseppe Argenziano talks about the role of Imiquimod in the treatment of primary melanoma. Using real patient case examples, Giuseppe describes the context in which Imiquimod can be utilised and the type of results physicians can expect. Continue reading “[3 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [May 2019]”

[3 min read] Long-term outcomes of laser for congenital melanocytic naevi

congenital melanocytic naevi

What are the long-term outcomes of laser treatment for congenital melanocytic naevi? Although various laser treatments have been tried for congenital melanocytic naevi, only small retrospective studies with short-term follow-up have been performed to assess outcomes. Continue reading “[3 min read] Long-term outcomes of laser for congenital melanocytic naevi”

[5 min read] Photodynamic therapy vs conventional treatments for basal cell carcinoma

Topical photodynamic therapy is an established treatment option for low‐risk basal cell carcinoma (BCC), but how does its efficacy, cosmesis and tolerability compare with alternative treatments? Continue reading “[5 min read] Photodynamic therapy vs conventional treatments for basal cell carcinoma”

[Review] Skin Cancer Summit & Masterclasses 2018

25 – 28 July 2018 | Brisbane 

The 10th Skin Cancer Summit & Masterclasses saw international thought leaders in skin cancer medicine converge in Brisbane to collaborate with GPs from across Australia. The 2018 program once again covered a broad range of topics relevant to doctors working in primary care skin cancer medicine. The Masterclasses focused on core day-to-day material, as a way to reinforce and extend knowledge. The two-day Summit opened up new areas of study, enquiry and interest.

      

 

Dermoscopy Masterclass: 25 July 2018

The first Masterclass focused on diagnosis through dermoscopy and was run by Prof Ash Marghoob (USA) and Dr Aimilios Lallas (Greece).

Dr Lallas used the concept of false positive and false negative diagnoses to reinforce our diagnostic accuracy. Clearly, as morphology overlaps the distinction between what is a cancer, and what is not, can provide confusion.

This broad concept was beautifully extended by Prof Marghoob through his presentation on difficult to diagnose melanomas. As we all know, the easy ones are easy. It is the hard-to-diagnose that we risk missing!

The session then moved into important body sites – the face and acral areas, which are important because the morphology of lesions on these sites is different from morphology on other sites. If we don’t understand this and know how the appearances differ, then we can’t accurately recognise cancers.

Our presenters then extended these important concepts to difficult to diagnose non-melanoma skin cancers, as it is not just melanomas that can be tricky. And, as always, we finished with a series of interactive cases.

 

Surgery Masterclass: 26 July 2018

The second Masterclass covered surgery of the ear. The ear, of course, is a common site for skin cancer because it is so exposed to solar damage. Ear surgery is important because cosmetic results are very visible to the patient and others. So, it is essential to get the surgery right, cure the cancer, and repair the defect as sympathetically as possible.

Dr Con Pappas and Dr Tony Azzi provided a comprehensive overview of how to prepare for and conduct surgery of the ear, across almost all imaginable lesions.

 

Summit: 27-28 July 2018

    

The Summit program is deliberately designed to be a mix of very practical, everyday material that supports our daily practice.

This year, key examples of these sessions were those on ‘effectiveness of dermoscopy’, ‘why we miss melanoma’, and ‘radiation oncology’. We also ran sessions that we hope will keep you and your patients safe, including ‘what interests the watchdog’ and ‘monitoring tips and traps’.

      

We deliberately moved into the future and sought to explore and speculate on what might be. It is clear that artificial intelligence is already with us, and yet most of us don’t really see what is happening and what might be coming. As educated and interested professionals, it is worth being aware of these trends.

We also like to keep you across what is happening outside clinical practice, in areas that are relevant to running your business. So, our sessions on how to run a successful business, and how others organise their own practices, are always very popular.

 

Skin Cancer Institute Gala Dinner

The Skin Cancer Summit closed with a Gala Dinner at the Queensland Cricketers’ Club. Hosted by the Skin Cancer Institute, the inaugural ‘White Out Skin Cancer’ Gala Dinner donated all proceeds to QIMR Berghofer. The delegates’ generosity and support will make a difference to many lives as we take a step closer to our vision of a world where nobody dies from skin cancer.